Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

7052 ARTíCULOS , VIENDO DEL 46 AL 60

PUBMED

Proteopathic Seed Amplification Assays for Neurodegenerative Disorders

Ferreira NDC, Caughey B.

Clin Lab Med. 2020 Sep;40(3):257-270. doi: 10.1016/j.cll.2020.04.002. Epub 2020 Jun 16.

0

0

0

PUBMED

Astaxanthin Suppresses PM2.5-Induced Neuroinflammation by Regulating Akt Phosphorylation in BV-2 Microglial Cells

Kim RE, Shin CY, Han SH, Kwon KJ.

Int J Mol Sci. 2020 Sep 30;21(19):E7227. doi: 10.3390/ijms21197227.

0

0

0

PUBMED

Vitamin B6 Deficiency in Patients With Parkinson Disease Treated With Levodopa/Carbidopa

Rojo-Sebastián A, González-Robles C, García de Yébenes J.

Clin Neuropharmacol. 2020 Sep/Oct;43(5):151-157. doi: 10.1097/WNF.0000000000000408.

0

0

0

PUBMED

Clinical Applications of Bee Venom Acupoint Injection

Lin TY, Hsieh CL.

Toxins (Basel). 2020 Sep 27;12(10):E618. doi: 10.3390/toxins12100618.

0

0

0

PUBMED

Understanding the mechanisms of placebo and nocebo effects

Frisaldi E, Shaibani A, Benedetti F.

Swiss Med Wkly. 2020 Sep 1;150:w20340. doi: 10.4414/smw.2020.20340. eCollection 2020 Aug 24.

0

0

0

PUBMED

Somatic Mutations in LRRK2 Identify a Subset of Invasive Mammary Carcinomas Associated with High Mutation Burden

Parrilla Castellar ER, Plichta JK, Davis R, Gonzalez-Hunt C, Sanders LH.

Am J Pathol. 2020 Sep 12:S0002-9440(20)30410-7. doi: 10.1016/j.ajpath.2020.08.010. Online ahead of print.

0

0

0

PUBMED

Insoluble Tau From Human FTDP-17 Cases Exhibit Unique Transmission Properties In Vivo

Weitzman SA, Narasimhan S, He Z, Changolkar L, McBride JD, Zhang B, Schellenberg GD, Trojanowski JQ, Lee VMY.

J Neuropathol Exp Neurol. 2020 Sep 1;79(9):941-949. doi: 10.1093/jnen/nlaa086.

0

0

0

PUBMED

Dopaminergic Retinal Cell Loss and Visual Dysfunction in Parkinson Disease

Ortuño-Lizarán I, Sánchez-Sáez X, Lax P, Serrano GE, Beach TG, Adler CH, Cuenca N.

Ann Neurol. 2020 Sep 3. doi: 10.1002/ana.25897. Online ahead of print.

0

0

0

PUBMED

Targeting Alternative Splicing as a Potential Therapy for Episodic Ataxia Type 2

Jaudon F, Baldassari S, Musante I, Thalhammer A, Zara F, Cingolani LA.

Biomedicines. 2020 Sep 5;8(9):E332. doi: 10.3390/biomedicines8090332.

0

0

0

PUBMED

Fibrillation and molecular characteristics are coherent with clinical and pathological features of 4-repeat tauopathy caused by MAPT variant G273R

Sandberg A, Ling H, Gearing M, Dombroski B, Cantwell L, R'Bibo L, Levey A, Schellenberg GD, Hardy J, Wood N, Fernius J, Nyström S, Svensson S, Thor S, Hammarström P, Revesz T, Mok KY.

Neurobiol Dis. 2020 Sep 19;146:105079. doi: 10.1016/j.nbd.2020.105079. Online ahead of print.

0

0

0

PUBMED

Potentially inappropriate prescribing in dementia, multi-morbidity and incidence of adverse health outcomes

Delgado J, Jones L, Bradley MC, Allan LM, Ballard C, Clare L, Fortinsky RH, Hughes CM, Melzer D.

Age Ageing. 2020 Sep 18:afaa147. doi: 10.1093/ageing/afaa147. Online ahead of print.

0

0

0

PUBMED

Vicia plants-A comprehensive review on chemical composition and phytopharmacology

Salehi B, Abu-Reidah IM, Sharopov F, Karazhan N, Sharifi-Rad J, Akram M, Daniyal M, Khan FS, Abbaass W, Zainab R, Carbone K, Fahmy NM, Al-Sayed E, El-Shazly M, Lucarini M, Durazzo A, Santini A, Martor

Phytother Res. 2020 Sep 15. doi: 10.1002/ptr.6863. Online ahead of print.

0

0

0

PUBMED

New Horizons: Novel Adrenal Regenerative Therapies

Bornstein SR, Malyukov M, Heller C, Ziegler CG, Ruiz-Babot G, Schedl A, Ludwig B, Steenblock C.

J Clin Endocrinol Metab. 2020 Sep 1;105(9):3103-7. doi: 10.1210/clinem/dgaa438.

0

0

0

PUBMED

Emendation of autophagic dysfuction in neurological disorders: a potential therapeutic target

Sainani SR, Pansare PA, Rode K, Bhalchim V, Doke R, Desai S.

Int J Neurosci. 2020 Sep 21:1-17. doi: 10.1080/00207454.2020.1822356. Online ahead of print.

0

0

0

PUBMED

Repurposing Pimavanserin, an Anti-Parkinson Drug for Pancreatic Cancer Therapy

Ramachandran S, Srivastava SK.

Mol Ther Oncolytics. 2020 Sep 2;19:19-32. doi: 10.1016/j.omto.2020.08.019. eCollection 2020 Dec 16.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy